Company Directory / pharmaceuticals
PrivateFor profitpharmaceuticalsChina
Shanghai Cell Therapy Group
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
- Founded
- 2013 13 years ago
- Staff
- 501-1000 band, as listed
- Followers
- - on LinkedIn
- Funding
- $2.3B as listed, currency not stated
Set against six million companies
Size
501-1000 people: larger than 95% of companies with a size listed
Age
13 years old.
Reach
Website ranked #8,610,872 in the world for traffic, about 500 visits a month.
What it does
BiotechnologyTherapeutics
Funding, as listed
$2.3B currency not stated
- Rounds4
- LatestSeries d, Mar 2021
- Investors7, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Shanghai Cell Therapy Group, field by field. Contact details are held but never shown.
The company
- Name
- Shanghai Cell Therapy Group
- Type
- For profit
- Status
- Private
- Founded
- 2013
- Industry
- pharmaceuticals
- Categories
- Biotechnology, Therapeutics
Where
- Country
- China
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 501-1000
- Web traffic rank
- #8,610,872
- Monthly web visits
- 500
Funding, as listed
- Total
- 2,260,000,000 (currency not stated)
- Rounds
- 4
- Latest round
- Series d
- Latest round date
- Mar 2021
- Investors
- 7
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Shanghai Cell Therapy Group may be growing as it is listed among key companies in the B-Cell Lymphoma clinical trial pipeline insights report. This inclusion suggests that the company is actively involved in research and development within the biotechnology and therapeutics industry. Being part of such a report indicates that Shanghai Cell Therapy Group is engaged in the development of treatments that could potentially meet the needs of a specific patient population. The company's association with the clinical trial pipeline for B-Cell Lymphoma also implies that it is contributing to advancements in the field, which is often a sign of growth and innovation in biotech companies.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
pharmaceuticals in China.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.